Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer

Fig. 1

Overall survival in the heterogeneous group of patients with non-small cell lung cancer, depending on number of 6 independent risk features (cigarette smoking, lack of chemotherapy, palliative doses of radiotherapy, high OPN concentration, advanced T stage and high VEGF concentration). Missing data were deleted (n = 227). The differences between the patients with 0–1, 2–4 and 5–6 risk features are highly significant (p < 0.00001)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us